2D-electrophoresis and multiplex immunoassay proteomic analysis of different body fluids and cellular components reveal known and novel markers for extended fasting

BMC Medical Genomics

Volumn 4, Issue , 2011, Pages

  Bouwman, Freek G ^a   De Roos, Baukje ^b   Rubio Aliaga, Isabel ^c   Crosley, L Katie ^b   Duthie, Susan J ^b   Mayer, Claus ^d   Horgan, Graham ^d   Polley, Abigael C ^e   Heim, Carolin ^c   Coort, Susan L M ^a   Evelo, Chris T ^a   Mulholland, Francis ^e   Johnson, Ian T ^e   Elliott, Ruan M ^e   Daniel, Hannelore ^c   Mariman, Edwin C M ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b ROWETT RESEARCH INSTITUTE   (United Kingdom)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^d BIOMATHEMATICS AND STATISTICS SCOTLAND   (United Kingdom)

^e NORWICH RESEARCH PARK   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACID PHOSPHATASE PROSTATE ISOENZYME; ALBUMIN; APOLIPOPROTEIN A1; APOLIPOPROTEIN A4; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CELL PROTEIN; CHLORIDE INTRACELLULAR CHLORIDE CHANNEL PROTEIN 1; INSULIN; INTERLEUKIN 1BETA; INTERLEUKIN 8; LEPTIN; MEMBRANE PROTEIN; RHO GUANOSINE DIPHOSPHATE DISSOCIATION INHIBITOR 2; SOMATOMEDIN C; STROMELYSIN; THYROTROPIN; UNCLASSIFIED DRUG; APOLIPOPROTEIN A; APOLIPOPROTEIN A-IV; ARHGDIB PROTEIN, HUMAN; GUANINE NUCLEOTIDE DISSOCIATION INHIBITOR; PROTEOME; TUMOR SUPPRESSOR PROTEIN;

ADULT; ARTICLE; BLOOD ANALYSIS; BODY FLUID; CONTROLLED STUDY; DIET RESTRICTION; FEMALE; HUMAN; HUMAN CELL; IMMUNOASSAY; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MULTIPLEX IMMUNOASSAY; NUCLEOTIDE SEQUENCE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEOMICS; RANDOM FOREST; SALIVA ANALYSIS; TANDEM MASS SPECTROMETRY; THROMBOCYTE; TWO DIMENSIONAL ELECTROPHORESIS; URINALYSIS; BLOOD; BLOOD CELL; CLUSTER ANALYSIS; MASS SPECTROMETRY; METABOLISM; METHODOLOGY; PRINCIPAL COMPONENT ANALYSIS; TIME; TWO DIMENSIONAL GEL ELECTROPHORESIS;

APOLIPOPROTEINS A; BIOLOGICAL MARKERS; BLOOD CELLS; BODY FLUIDS; CLUSTER ANALYSIS; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FASTING; GUANINE NUCLEOTIDE DISSOCIATION INHIBITORS; HUMANS; IMMUNOASSAY; LEPTIN; MASS SPECTROMETRY; MATRIX METALLOPROTEINASE 3; PRINCIPAL COMPONENT ANALYSIS; PROTEOME; PROTEOMICS; TIME FACTORS; TUMOR SUPPRESSOR PROTEINS;

EID: 79953078408     PISSN: None     EISSN: 17558794     Source Type: Journal    
DOI: 10.1186/1755-8794-4-24     Document Type: Article

References (48)

1. OMICS-driven biomarker discovery in nutrition and health. M Kussmann F Raymond M Affolter, Journal of biotechnology 2006 124 4 758 787 10.1016/j.jbiotec.2006.02.014 16600411 (Pubitemid 44088435)
2. Nutrition proteomics and biomarker discovery. B de Roos, Expert review of proteomics 2009 6 4 349 351 10.1586/epr.09.52 19681670
3. Proteomics as a tool for the modelling of biological processes and biomarker development in nutrition research. B de Roos HJ McArdle, The British journal of nutrition 2008 99 Suppl 3 66 71 18598591
4. Fasting - the ultimate diet? AM Johnstone, Obes Rev 2007 8 3 211 222 10.1111/j.1467-789X.2006.00266.x 17444963 (Pubitemid 46632687)
5. A "mini-fast with exercise" protocol for fat loss. B Bahadori MF McCarty J Barroso-Aranda JC Gustin F Contreras, Medical hypotheses 2009 73 4 619 622 10.1016/j.mehy.2008.09.063 19577377
6. Fuel metabolism in starvation. GF Cahill Jr, Annual review of nutrition 2006 26 1 22 10.1146/annurev.nutr.26.061505.111258 16848698
7. The NuGO proof of principle study package: a collaborative research effort of the European Nutrigenomics Organisation. M Baccini EM Bachmaier A Biggeri MV Boekschoten FG Bouwman L Brennan R Caesar S Cinti SL Coort K Crosley,, et al. Genes & nutrition 2008 3 3-4 147 151
8. Metabolomics of prolonged fasting in humans: from physiology to individual metabotypes. I Rubio-Aliaga B de Roos SJ Duthie LK Crosley C Mayer G Horgan IJ Colquhoun G Le Gall F Huber W Kremer,, et al. Metabolomics
9. Profiling techniques in nutrition and health research. M Kussmann S Rezzi H Daniel, Current opinion in biotechnology 2008 19 2 83 99 10.1016/j.copbio. 2008.02.003 18378135
10. Variation in protein levels obtained from human blood cells and biofluids for platelet, peripheral blood mononuclear cell, plasma, urine and saliva proteomics. LK Crosley SJ Duthie AC Polley FG Bouwman C Heim F Mulholland G Horgan IT Johnson EC Mariman RM Elliott,, et al. Genes & nutrition 2009 4 2 95 102
11. Proteomic methodological recommendations for studies involving human plasma, platelets, and peripheral blood mononuclear cells. B de Roos SJ Duthie AC Polley F Mulholland FG Bouwman C Heim GJ Rucklidge IT Johnson EC Mariman H Daniel,, et al. Journal of proteome research 2008 7 6 2280 2290 10.1021/pr700714x 18489134
12. Evaluation and improving the success rate of protein identification by peptide mass fingerprinting using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. F Bouwman D Suylen J Renes E Mariman, Rapid Commun Mass Spectrom 2005 19 17 2465 2468 10.1002/rcm.2073 16059887 (Pubitemid 41284997)
13. The circulating inactive form of matrix Gla Protein (ucMGP) as a biomarker for cardiovascular calcification. EC Cranenburg C Vermeer R Koos ML Boumans TM Hackeng FG Bouwman M Kwaijtaal VM Brandenburg M Ketteler LJ Schurgers, Journal of vascular research 2008 45 5 427 436 10.1159/000124863 18401181
14. Proteome analysis suggests that mitochondrial dysfunction in stressed endothelial cells is reversed by a soy extract and isolated isoflavones. D Fuchs B Dirscherl JH Schroot H Daniel U Wenzel, Journal of proteome research 2007 6 6 2132 2142 10.1021/pr060547y 17503794 (Pubitemid 46985099)
15. Random forests. L Breiman, Machine Learning 2001 45 1 5 32 10.1023/A:1010933404324 (Pubitemid 32933532)
16. Integrating and annotating the interactome using the MiMI plugin for cytoscape. J Gao AS Ade VG Tarcea TE Weymouth BR Mirel HV Jagadish DJ States, Bioinformatics (Oxford, England) 2009 25 1 137 138 10.1093/bioinformatics/btn501 18812364
17. Variation in gene expression profiles of peripheral blood mononuclear cells from healthy volunteers. JJ Eady GM Wortley YM Wormstone JC Hughes SB Astley RJ Foxall JF Doleman RM Elliott, Physiol Genomics 2005 22 3 402 411 10.1152/physiolgenomics.00080.2005 16014386 (Pubitemid 41356372)
18. Defining the mandate of proteomics in the post-genomics era: workshop report. GL Kenyon DM DeMarini E Fuchs DJ Galas JF Kirsch TS Leyh WH Moos GA Petsko D Ringe GM Rubin,, et al. Mol Cell Proteomics 2002 1 10 763 780 12438560
19. A Multiplex Immunoassay for Human Adipokine Profiling. HS Schipper W de Jager ME van Dijk J Meerding PM Zelissen RA Adan BJ Prakken E Kalkhoven, Clinical chemistry 2010 56 8 1320 1328 10.1373/clinchem.2010.146118 20530731
20. Amazing chloride channels: an overview. B Nilius G Droogmans, Acta physiologica Scandinavica 2003 177 2 119 147 10.1046/j.1365-201X.2003.01060.x 12558550 (Pubitemid 36197504)
21. Generally detected proteins in comparative proteomics - a matter of cellular stress response? P Wang FG Bouwman EC Mariman, Proteomics 2009 9 11 2955 2966 10.1002/pmic.200800826 19415655
22. Differential intracellular localizations of GDP dissociation inhibitor isoforms. Insulin-dependent redistribution of GDP dissociation inhibitor-2 in 3T3-L1 adipocytes. A Shisheva J Buxton MP Czech, The Journal of biological chemistry 1994 269 39 23865 23868 7929030
23. Apolipoprotein A-IV: a circulating satiety signal produced by the small intestine. P Tso Q Chen K Fujimoto K Fukagawa T Sakata, Obesity research 1995 3 Suppl 5 689S 695S 8653550
24. A proteomic approach to identify differentially expressed plasma proteins between the fed and prolonged fasted states. F Bertile C Schaeffer Y Le Maho T Raclot A Van Dorsselaer, Proteomics 2009 9 1 148 158 10.1002/pmic.200701001 19053136
25. Animal protein intake, serum insulin-like growth factor I, and growth in healthy 2.5-y-old Danish children. C Hoppe TR Udam L Lauritzen C Molgaard A Juul KF Michaelsen, The American journal of clinical nutrition 2004 80 2 447 452 15277169
26. Short-term effects of replacing milk with cola beverages on insulin-like growth factor-I and insulin-glucose metabolism: a 10 d interventional study in young men. C Hoppe M Kristensen M Boiesen J Kudsk K Fleischer Michaelsen C Molgaard, The British journal of nutrition 2009 102 7 1047 1051 10.1017/S0007114509338829 19772696
27. Calorie restriction and cancer prevention: metabolic and molecular mechanisms. VD Longo L Fontana, Trends in pharmacological sciences 2010 31 2 89 98 10.1016/j.tips.2009.11.004 20097433
28. Acute stimulation of leptin concentrations in humans during hyperglycemic hyperinsulinemia. Influence of free fatty acids and fasting. N Stefan A Fritsche H Haring M Stumvoll, Int J Obes Relat Metab Disord 2001 25 1 138 142 10.1038/sj.ijo.0801527 11244470 (Pubitemid 32142396)
29. Short-term fasting-induced autonomic activation and changes in catecholamine levels are not mediated by changes in leptin levels in healthy humans. JL Chan JE Mietus PM Raciti AL Goldberger CS Mantzoros, Clinical endocrinology 2007 66 1 49 57 17201801 (Pubitemid 44952494)
30. Role of leptin in the neuroendocrine response to fasting. RS Ahima D Prabakaran C Mantzoros D Qu B Lowell E Maratos-Flier JS Flier, Nature 1996 382 6588 250 252 10.1038/382250a0 8717038 (Pubitemid 26251358)
31. Leptin does not mediate short-term fasting-induced changes in growth hormone pulsatility but increases IGF-I in leptin deficiency states. JL Chan CJ Williams P Raciti J Blakeman T Kelesidis I Kelesidis ML Johnson MO Thorner CS Mantzoros, The Journal of clinical endocrinology and metabolism 2008 93 7 2819 2827 10.1210/jc.2008-0056 18445667 (Pubitemid 352008557)
32. Long-term calorie restriction is highly effective in reducing the risk for atherosclerosis in humans. L Fontana TE Meyer S Klein JO Holloszy, Proceedings of the National Academy of Sciences of the United States of America 2004 101 17 6659 6663 10.1073/pnas.0308291101 15096581 (Pubitemid 38586030)
33. Inverse relationship between plasma adiponectin and leptin concentrations in normal-weight and obese women. M Matsubara S Maruoka S Katayose, European journal of endocrinology/European Federation of Endocrine Societies 2002 147 2 173 180 12153737
34. Evidence for a protective role for adiponectin in osteoarthritis. TH Chen L Chen MS Hsieh CP Chang DT Chou SH Tsai, Biochimica et biophysica acta 2006 1762 8 711 718 16891099 (Pubitemid 44293372)
35. Adiponectin specifically increased tissue inhibitor of metalloproteinase-1 through interleukin-10 expression in human macrophages. M Kumada S Kihara N Ouchi H Kobayashi Y Okamoto K Ohashi K Maeda H Nagaretani K Kishida N Maeda,, et al. Circulation 2004 109 17 2046 2049 10.1161/01.CIR. 0000127953.98131.ED 15096450 (Pubitemid 38620209)
36. Independent association between plasma leptin and C-reactive protein in healthy humans. AS Shamsuzzaman M Winnicki R Wolk A Svatikova BG Phillips DE Davison PB Berger VK Somers, Circulation 2004 109 18 2181 2185 10.1161/01.CIR.0000127960.28627.75 15117839 (Pubitemid 38625394)
37. Induction of leptin resistance through direct interaction of C-reactive protein with leptin. K Chen F Li J Li H Cai S Strom A Bisello DE Kelley M Friedman-Einat GA Skibinski MA McCrory,, et al. Nature medicine 2006 12 4 425 432 10.1038/nm1372 16582918
38. Human leptin forms complexes with alpha 2-macroglobulin which are recognized by the alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein. G Birkenmeier I Kampfer J Kratzsch W Schellenberger, European journal of endocrinology/European Federation of Endocrine Societies 1998 139 2 224 230 9724081 (Pubitemid 28389683)
39. Inactivation of plasminogen activator inhibitor-1 by specific proteolysis with stromelysin-1 (MMP-3). HR Lijnen B Arza B Van Hoef D Collen PJ Declerck, The Journal of biological chemistry 2000 275 48 37645 37650 10.1074/jbc. M006475200 10967118 (Pubitemid 32004876)
40. Matrix metalloproteinase processing of monocyte chemoattractant proteins generates CC chemokine receptor antagonists with anti-inflammatory properties in vivo. GA McQuibban JH Gong JP Wong JL Wallace I Clark-Lewis CM Overall, Blood 2002 100 4 1160 1167 12149192 (Pubitemid 34864266)
41. Adipocyte extracellular matrix composition, dynamics and role in obesity. EC Mariman P Wang, Cell Mol Life Sci 2010 67 8 1277 1292 10.1007/s00018-010- 0263-4 20107860
42. Subcutaneous abdominal, but not femoral fat expression of plasminogen activator inhibitor-1 (PAI-1) is related to plasma PAI-1 levels and insulin resistance and decreases after weight loss. A Mavri MC Alessi D Bastelica O Geel-Georgelin F Fina JT Sentocnik M Stegnar I Juhan-Vague, Diabetologia 2001 44 11 2025 2031 10.1007/s001250100007 11719834 (Pubitemid 33124048)
43. Impact of weight reduction on production of platelet-derived microparticles and fibrinolytic parameters in obesity. T Murakami H Horigome K Tanaka Y Nakata K Ohkawara Y Katayama A Matsui, Thrombosis research 2007 119 1 45 53 10.1016/j.thromres.2005.12.013 16480759 (Pubitemid 44716205)
44. A low-glycemic-index diet reduces plasma plasminogen activator inhibitor-1 activity, but not tissue inhibitor of proteinases-1 or plasminogen activator inhibitor-1 protein, in overweight women. L Jensen B Sloth I Krog-Mikkelsen A Flint A Raben T Tholstrup N Brunner A Astrup, The American journal of clinical nutrition 2008 87 1 97 105 18175742
45. The plasminogen activator and matrix metalloproteinase systems in colorectal cancer: relationship to tumour pathology. EA Baker DJ Leaper, Eur J Cancer 2003 39 7 981 988 10.1016/S0959-8049(03)00065-0 12706368 (Pubitemid 36428631)
46. Matrix metalloproteinases are differentially expressed in adipose tissue during obesity and modulate adipocyte differentiation. C Chavey B Mari MN Monthouel S Bonnafous P Anglard E Van Obberghen S Tartare-Deckert, The Journal of biological chemistry 2003 278 14 11888 11896 10.1074/jbc.M209196200 12529376 (Pubitemid 36800160)
47. Do inflammation and procoagulation biomarkers contribute to the metabolic syndrome cluster? AT Kraja MA Province D Arnett L Wagenknecht W Tang PN Hopkins L Djousse IB Borecki, Nutrition & metabolism 2007 4 28
48. Adipose tissue activity in relation to overweight or obesity. M Gnacinska S Malgorzewicz M Guzek W Lysiak-Szydlowska K Sworczak, Endokrynologia Polska 2010 61 2 160 168 20464701